Purpose: To describe the clinical and swept source OCT angiographic features of a patient with acute syphilitic posterior placoid chorioretinitis (ASPPC). Observations: A 67-year-old man presented with acute loss of vision in the left eye. On exam, we noted a yellowish placoid lesion in the macula. Optical coherence tomography (OCT) imaging showed RPE nodularity and disruption of the inner segment-outer segment region in the left eye. Fluorescein angiography showed early hyperfluorescent and late staining within the placoid lesions. Wide field swept source OCT angiography (SS-OCTA) showed macular choriocapillaris perfusion flow deficits. Laboratory tests revealed positive 1:128 rapid plasma reagin titer and fluorescent treponemal antibody absorption (FTA-ABS) tests. OCT imaging revealed complete restoration of the IS-OS boundary layer with near complete resolution of the RPE granularity after adequate penicillin therapy. SS-OCTA showed resolution of choriocapillaris flow deficit in the left eye. Improvement in BCVA correlated with improvement in choriocapillaris perfusion. Conclusions and importance: This is the first case that describes long-term SS-OCTA findings in ASPPC. SS-OCTA is a fast, safe, and easily repeatable imaging modality that offers valuable insights in our understanding of the pathophysiology and the response to treatment of ASPPC.
Introduction
Acute syphilitic posterior placoid chorioretinitis (ASPPC) is a rare manifestation of ocular syphilis characterize by a rounded, yellowish, placoid lesion in the macula or the posterior pole. 1 Syphilitic ocular involvement is more frequently observed in the secondary and tertiary stages of the disease. 2 With the recent worldwide rise in the incidence of syphilis, clinicians should have a high index of suspicion when evaluating patients with ocular inflammation even in the absence of other syphilitic manifestations. 3 In this case report, we present the evolution over one year of multimodal imaging including macular choriocapillaris perfusion on swept source OCT angiography (SS-OCTA) in a patient treated for ASPPC.
Case report
A 67-year-old man presented to Bascom Palmer Eye Institute complaining of acute vision loss in the left eye of 9 days duration. He gave a medical history of an epidural steroid injection 1 month prior to his presentation. He had a history of genital herpes and was on valacyclovir prophylactic therapy. He denied any viral prodrome or recent illness.
He was diagnosed with central serous chorioretinopathy by an outside physician. His best corrected visual acuity (BCVA) was 20/20 in his right eye and 20/125 in the left eye. Intraocular pressure was normal. His anterior segment exam was unremarkable. Funduscopic examination and color fundus imaging showed a normal right eye and a yellow placoid lesion involving the macula in the left eye ( Fig. 1 ). Fundus autofluorescence revealed foci of punctate hyper-autofluorescence in the area of the placoid lesion in the left eye ( Fig. 1 ). Swept source OCT (SS-OCT; PLEX Elite 9000; Carl Zeiss Meditec, Inc, Dublin, CA) imaging showed a normal right eye, while in the left eye, hyperreflective foci were identified along the anterior surface of the retinal pigment epithelium (RPE) along with disruption of the inner segment-outer segment (IS-OS) junction ( Fig. 2H ) and thickening of the macular retina ( Fig. 2 B ). An en face structural slab with boundaries that included the inner segment-outer segment (IS-OS) region showed scattered hyperreflective spots ( Fig. 2 D) that corresponded to the hyper-reflective foci seen on the B-scan. En face SS-OCT angiography (SS-OCTA) imaging using a choroidal slab adjacent to the RPE in the region of the choriocapillaris showed decreased flow associated with the placoid lesion in the left eye ( Fig. 3 ). An inspection of the corresponding structural image shows that the decreased detection of flow cannot be explained by the https://doi.org/10.1016/j.ajoc.2020.100678 Received 27 November 2019; Received in revised form 17 March 2020; Accepted 24 March 2020 presence of uneven illumination or a transmission defect. SS-OCTA imaging was normal in the right eye.
Five days later, the patient was seen by a uveitis specialist. His BCVA decreased to 20/200 in the left eye. On slit lamp examination, trace anterior vitritis was seen in the right eye and 1+ anterior vitritis was observed in the left eye. Fundus exam of the left eye revealed expansion of the yellow placoid lesion beyond the superior and inferior arcades with evidence of stippled RPE hyperpigmentation. The right eye continued to appear normal. Widefield autofluorescence imaging showed patches of hyper-autofluorescence inferior and inferonasal to the optic nerve in the right eye and stippled hyper-autofluorescence in the left eye corresponding to the placoid lesion ( Fig. 4 ). Fluorescein angiography (FA) showed early faint hyperfluorescence and late staining without leakage in both eyes ( Fig. 4 ), and indocyanine green angiography (ICGA) showed early and late hypofluorescence in the corresponding areas ( Fig. 5 ). Upon further questioning, the patient disclosed a positive HIV history. Laboratory tests revealed positive 1:128 rapid plasma reagin titer and fluorescent treponemal antibody absorption (FTA-ABS) tests. Cerebrospinal fluid (CSF) Venereal Disease Research Laboratory (VDRL) test was also reactive, and findings were consistent with the diagnosis of neurosyphilis. He denied any ulcers or mucocutaneous lesions or other systemic symptoms. Brain MRI imaging was unremarkable. The patient was started on intravenous penicillin G treatment.
One month later, his BCVA improved to 20/20 in the left eye. There was resolution of intraocular inflammation. The placoid lesion resolved on fundus exam. There was partial restoration of the IS-OS junction in the left eye with decreased RPE granularity ( Fig. 6 ). SS-OCTA imaging showed gradual resolution of the choriocapillaris flow deficits in the left eye ( Fig. 7) . At 12 months follow up, BCVA remained 20/20 in both eyes. SS-OCT imaging revealed complete restoration of the IS-OS boundary layer with near complete resolution of the RPE granularity ( Fig. 6 ). SS-OCTA imaging revealed restoration of choriocapillaris perfusion in both eyes (Fig. 7) . The SS-OCT thickness map showed resolution of the macular thickening in the left eye noted at presentation ( Fig. 6 ).
Discussion
The term ASPPC was coined by Gass et al. to characterize single or several placoid yellowish lesions at the level of the retinal pigment epithelium and outer retina in the macula and juxtapapillary regions. 1 Similarly to prior studies, we noted localized hyper-autofluorescence in the area of the placoid lesion that corresponded to the granular deposits on the RPE. 4 The hyper-autofluorescence noted in the lesions of both eyes may be a consequence of photoreceptor outer segment abnormalities that correspond to an increase in the detection of RPE autofluorescence. 5 It may also be the result of RPE dysfunction leading to incomplete phagocytosis of outer segments with accumulation of photoreceptor outer segment material between the photoreceptors and RPE. 4 Widefield autofluorescence also revealed focal patchy areas of increased autofluorescence that otherwise appeared normal on fundus exam. This finding was also noted by Tsui et al. 6 Our patient also had OCT findings previously reported with syphilis, including irregular nodular thickening of the RPE, external limiting membrane disruption, and segmental loss of the IS-OS region reflectivity. [7] [8] [9] While subretinal fluid has been reported as an early transient feature in patients with ASPPC who had imaging performed within the first few days of onset of symptoms, 8 we did not detect subretinal fluid in our patient, perhaps due to his delayed presentation to our office. After initiating antibiotic treatment, we observed gradual improvement of OCT findings as seen in other reports. 7, 9 Some authors report complete resolution of OCT abnormalities, which we have not yet observed in our patient. 10, 11 En face images segmented at the level of IS-OS region demonstrated hyperreflective lesions that correlated to the RPE nodular deposits seen on OCT B-scans, and these lesions gradually improved with therapy resulting in total restoration of the IS-OS region and near complete resolution of the RPE granularity. While our patient was HIV positive and tested positive for both VDRL and FTA-ABS, it is noteworthy that the clinical features of ASPPC in both HIV-positive and HIV-negative patients are similar. 7 Using SS-OCTA imaging and a widefield 12 × 12 mm field of view scans with slabs that encompassed the anterior choroidal vasculature, which included the choriocapillaris, we were able to document decreased perfusion that we interpreted as diminished choriocapillaris flow that corresponded to the placoid lesion. Decreased choriocapillaris perfusion was reported previously in a smaller scan area. 6 This reduced anterior choroidal flow appears to be real and not the result of a shadow artifact from the overlying vitreous or retina. With appropriate treatment, areas of decreased choriocapillaris flow appeared to improve. Improvement in BCVA to 20/20 correlated with improvement in choriocapillaris perfusion despite subtle persistent outer retinal abnormalities. As a result, we speculate that detection of choriocapillaris perfusion abnormalities may help predict final visual acuity outcomes in ASPPC. Other authors have speculated on the impact of decreased choriocapillaris perfusion on visual acuity in various chorioretinal diseases such as macular degeneration, and these choriocapillaris abnormalities likely affect vision indirectly by causing RPE dysfunction. 12, 13 Visual prognosis for ASPPC patients is usually good after adequate therapy, and our observed improvement in vision correlated with the improvement in choriocapillaris perfusion.
The pathophysiology of ASPPC is not clearly understood. Gass et al. postulated that an inflammatory reaction was present at the level of the choriocapillaris-RPE-photoreceptor complex. 1 Later studies using ICGA, FAF, and SD-OCT have been in accordance with this theory. 9, 11 Our present case demonstrates transient disruptions of choriocapillaris perfusion and outer retinal architecture on SS-OCTA imaging that support the theory regarding the inflammatory involvement of the inner choroid and outer retina in ASPPC. Additional studies are needed to demonstrate the role of the choriocapillaris in predicting visual acuity outcomes following treatment of ASPPC as well as the role of SS-OCTA imaging in differentiating various placoid diseases and their response to treatment.
Conclusion
This is the first case report to describe long-term SS-OCTA imaging in ASPPC. SS-OCTA is a fast, safe, and easily repeatable imaging modality that offers valuable insights in our understanding of the pathophysiology and the response to treatment of this condition by providing both structural and flow information of the retina and choroid over a 40-degree 12 × 12 mm field of view at baseline and at frequent follow-up visits.
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